<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//farmak.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-ag-kuendigt-rebranding-an/</loc>
		<lastmod>2024-09-25T12:37:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-ag-announces-its-rebranding/</loc>
		<lastmod>2024-09-26T11:54:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-ag-acquires-polish-pharmaceutical-company-symphar/</loc>
		<lastmod>2024-09-26T12:18:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-ag-erwirbt-die-polnische-pharmaunternehmen-symphar-sp-z-o-o/</loc>
		<lastmod>2024-09-27T06:42:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/erwerb-von-as-pharma-holdings-ltd-hauptsitz-in-grossbritannien/</loc>
		<lastmod>2024-12-17T11:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/acquisition-of-as-pharma-holdings-ltd-uk-based/</loc>
		<lastmod>2024-12-17T11:33:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-secures-first-marketing-authorization-in-china-for-mri-contrast-agent/</loc>
		<lastmod>2025-01-21T08:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/where-to-meet-farmak-international-in-2025-lets-talk-business/</loc>
		<lastmod>2025-02-11T14:12:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-successfully-completes-aseptic-process-simulation-at-spanish-manufacturing-site/</loc>
		<lastmod>2025-02-17T13:28:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-at-ecr-2025-expanding-global-access-to-essential-pharmaceutical-solutions-in-radiology/</loc>
		<lastmod>2025-03-05T12:45:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-gains-key-uk-authorizations-mia-wdah-secured/</loc>
		<lastmod>2025-03-28T15:13:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-finalizes-integration-of-symphar-poland/</loc>
		<lastmod>2025-04-02T08:08:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-expands-uk-portfolio-with-three-new-mhra-approved-therapies/</loc>
		<lastmod>2025-05-07T13:30:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-strengthens-uk-portfolio-with-two-new-mhra-approved-therapies/</loc>
		<lastmod>2025-05-23T11:52:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-delivers-first-commercial-shipment-of-gadoteric-acid-to-china-under-the-10th-national-vbp-programme/</loc>
		<lastmod>2025-05-26T11:53:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-launches-propofol-in-the-uk-market/</loc>
		<lastmod>2025-05-29T20:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/uk-grants-ma-to-farmak-manufactured-vitamin-therapy-to-support-icu-supply-from-june-2025/</loc>
		<lastmod>2025-06-05T14:40:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-staerkt-britisches-portfolio-mit-zwei-neuen-mhra-zugelassenen-therapien/</loc>
		<lastmod>2025-06-12T11:28:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-liefert-erste-kommerzielle-charge-gadotersaeure-nach-china-auftrag-aus-der-10-nationalen-vbp-runde-erfuellt/</loc>
		<lastmod>2025-06-12T12:00:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-erweitert-britisches-portfolio-um-drei-neue-mhra-zugelassene-therapien/</loc>
		<lastmod>2025-06-12T12:17:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-schliesst-integration-von-symphar-in-polen-ab/</loc>
		<lastmod>2025-06-12T12:26:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-confirms-bioequivalence-for-10-mg-tofacitinib-uk-filing-on-track/</loc>
		<lastmod>2025-06-23T08:27:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/power-your-second-half-of-2025-portfolio-with-our-top-5-partner-picks/</loc>
		<lastmod>2025-07-10T10:09:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-shares-inside-look-at-its-new-aseptic-facility-in-spain/</loc>
		<lastmod>2025-11-26T13:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/where-to-meet-farmak-international-in-2026/</loc>
		<lastmod>2026-01-06T13:58:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/icm-farmak-receives-first-eu-gmp-certification-for-sterile-manufacturing-in-spain/</loc>
		<lastmod>2026-01-19T13:11:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-bestaetigt-bioaequivalenz-fuer-10-mg-tofacitinib-uk-einreichung-im-plan/</loc>
		<lastmod>2026-02-18T16:01:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/uk-zulassung-fuer-farmak-gefertigte-vitamin-b-c-injektion-icu-versorgung-ab-juni-2025/</loc>
		<lastmod>2026-02-18T16:02:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-bringt-propofol-auf-den-britischen-markt/</loc>
		<lastmod>2026-02-18T16:02:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/3-neue-zulassungen-staerken-die-praesenz-von-farmak-international-in-tschechien/</loc>
		<lastmod>2026-02-18T16:03:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-liefert-vasopressin-erstmals-nach-katar/</loc>
		<lastmod>2026-02-18T16:03:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/3-new-authorisations-strengthen-farmak-internationals-czech-footprint/</loc>
		<lastmod>2026-02-18T16:03:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-at-cphi-2025-advancing-sterile-injectables-globally/</loc>
		<lastmod>2026-02-18T16:03:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-delivered-vasopressin-to-qatar-in-its-first-export-to-the-market/</loc>
		<lastmod>2026-02-18T16:04:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/who-confirms-prequalification-status-for-dexamethasone-sodium-phosphate-injection/</loc>
		<lastmod>2026-02-18T16:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-secures-over-50-uk-marketing-authorisations-in-2025/</loc>
		<lastmod>2026-02-23T13:58:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-partners-with-oxford-pharmacy-store-for-uk-contrast-media-distribution/</loc>
		<lastmod>2026-02-26T13:36:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-enters-strategic-distribution-agreement-with-united-medical-supplies-unimed-llc-in-the-uae/</loc>
		<lastmod>2026-04-09T09:21:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-reports-23-product-launches-in-q1-2026/</loc>
		<lastmod>2026-04-10T11:41:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/de/presseinfos/farmak-international-berichtet-ueber-23-produkteinfuehrungen-im-ersten-quartal-2026/</loc>
		<lastmod>2026-04-10T12:06:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-strengthens-its-presence-in-spain-with-new-marketing-authorisations-for-contrast-agents/</loc>
		<lastmod>2026-05-05T11:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/dcat-week-2026-farmak-international-heads-to-new-york/</loc>
		<lastmod>2026-05-28T08:54:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-opens-new-office-in-mexico-city-strengthening-its-presence-in-latin-america/</loc>
		<lastmod>2026-06-08T08:47:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-to-exhibit-at-cphi-sea-2026-in-bangkok/</loc>
		<lastmod>2026-06-08T08:49:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-receives-marketing-authorizations-for-gadobutrol-in-europe/</loc>
		<lastmod>2026-06-08T08:50:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/7-new-launches-in-the-uk-market-during-q1/</loc>
		<lastmod>2026-06-08T08:50:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-receives-silver-sustainability-booth-design-award-at-cphi-sea-2026/</loc>
		<lastmod>2026-07-09T11:30:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-receives-another-marketing-authorisation-in-spain/</loc>
		<lastmod>2026-07-20T08:44:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/icm-farmak-expands-gmp-certified-capabilities-with-in-house-sterility-testing/</loc>
		<lastmod>2026-07-30T09:14:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/icm-farmak-expands-its-authorized-activities-in-spain/</loc>
		<lastmod>2026-07-30T09:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://farmak.com/press-releases/farmak-international-completes-17-launches-across-9-markets-this-summer/</loc>
		<lastmod>2026-09-11T13:52:45+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->